<div id="readability-page-1"><div><p>Healthcare is among the worst-performing sectors as Wall Street starts December reversing Black Friday gains.</p><p>    Citius Oncology shares climbed after the company commercially launched its treatment Lymphir for patients with a rare type of cancer that affects the skin. </p><p>    Shares of vaccine makers fall as a FDA official's memo outlined a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children. </p><p>    Eli Lilly cut prices of its Zepbound drug single-dose vials on its direct-to-consumer platform after it lowered prices of its multi-dose pens last month. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-01-25 1659ET</p></div></div>

礼来

CTOR

<p>医疗股表现不佳，华尔街逆转了黑色星期五的涨幅。Citius Oncology 的股票在推出针对一种罕见皮肤癌的 Lymphir 后上涨。由于 FDA 的一份备忘录将 COVID-19 mRNA 疫苗与儿童心肌炎死亡事件联系起来，疫苗制造商的股票下跌。礼来在其直接面向消费者的平台上降低了 Zepbound 药瓶的价格</p>

医疗保健股票回吐了部分近期的涨幅 -- 医疗保健综述